US Patent 11517621 Treatment of severe community acquired pneumonia
Patent 11517621 was granted and assigned to Biotest AG on December, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Andrea Wartenberg-Demand0
Benjamin Daelken0
Patrick Langohr0
Ulrike Wippermann0
Edits on 7 Dec, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+284 characters)
US Patent 11517621 Treatment of severe community acquired pneumonia
Article
The present invention provides for a new therapeutic tools capable of treating infectious diseases, in particular, a new pharmaceutical composition comprising an IgM-enriched immunoglobulin preparation for use in the adjunctive treatment of severe Community Acquired Pneumonia (sCAP).
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115176210
Date of Patent
December 6, 2022
0Patent Application Number
171499270
Date Filed
January 15, 2021
0Patent Primary Examiner
Find more entities like US Patent 11517621 Treatment of severe community acquired pneumonia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.